Alaunos Therapeutics, Inc.盘中异动大幅下挫6.37%报2.50美元

市场透视2025-04-17

北京时间2025年04月17日22时11分，Alaunos Therapeutics, Inc.（TCRT.us）股票出现波动，股价快速下跌6.37%。截至发稿，该股报2.50美元/股，成交量4311股，换手率0.27%，振幅2.02%。最近的财报数据显示，该股实现营业收入10000.00美元，净利润-4.68百万美元，每股收益-2.92美元，毛利8000.00美元，市盈率-0.88倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2528040741?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-17 22:11","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2528040741","market":"us","top_or_hot":-1,"title":"Alaunos Therapeutics, Inc.盘中异动 大幅下挫6.37%报2.50美元","media":"市场透视","content":"<div>\n<p>北京时间2025年04月17日22时11分，Alaunos Therapeutics, Inc.（TCRT.us）股票出现波动，股价快速下跌6.37%。截至发稿，该股报2.50美元/股，成交量4311股，换手率0.27%，振幅2.02%。最近的财报数据显示，该股实现营业收入10000.00美元，净利润-4.68百万美元，每股收益-2.92美元，毛利8000.00美元，市盈率-0.88倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722113194d8dc57&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alaunos Therapeutics, Inc.盘中异动 大幅下挫6.37%报2.50美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlaunos Therapeutics, Inc.盘中异动 大幅下挫6.37%报2.50美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-17 22:11 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722113194d8dc57&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月17日22时11分，Alaunos Therapeutics, Inc.（TCRT.us）股票出现波动，股价快速下跌6.37%。截至发稿，该股报2.50美元/股，成交量4311股，换手率0.27%，振幅2.02%。最近的财报数据显示，该股实现营业收入10000.00美元，净利润-4.68百万美元，每股收益-2.92美元，毛利8000.00美元，市盈率-0.88倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722113194d8dc57&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722113194d8dc57&s=b","article_id":"2528040741","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722113194d8dc57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2528040741","pubTimestamp":1744899091,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月17日22时11分，Alaunos Therapeutics, Inc.股票出现波动，股价快速下跌6.37%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、Radiopharm Theranostics Limited涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为525.18%、158.34%、92.13%，振幅较大的相关个股有Channel Therapeutics Corporation、Processa Pharmaceuticals, Inc.、Kazia Therapeutics Limited，振幅分别为43.82%、43.27%、29.38%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","TCRT":"Alaunos Therapeutics","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Alaunos Therapeutics, Inc. fell 6.37% to $2.50 in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TCRT":1,"LENZ":1},"content_text":"北京时间2025年04月17日22时11分，Alaunos Therapeutics, Inc.（TCRT.us）股票出现波动，股价快速下跌6.37%。截至发稿，该股报2.50美元/股，成交量4311股，换手率0.27%，振幅2.02%。最近的财报数据显示，该股实现营业收入10000.00美元，净利润-4.68百万美元，每股收益-2.92美元，毛利8000.00美元，市盈率-0.88倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、Radiopharm Theranostics Limited涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为525.18%、158.34%、92.13%，振幅较大的相关个股有Channel Therapeutics Corporation、Processa Pharmaceuticals, Inc.、Kazia Therapeutics Limited，振幅分别为43.82%、43.27%、29.38%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。 该公司通过设计针对基因组突变产生的新抗原的细胞疗法来打击癌症的核心。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2528040741","isCrawlerRequest":true}

Alaunos Therapeutics, Inc.盘中异动 大幅下挫6.37%报2.50美元

精彩评论

Alaunos Therapeutics, Inc.盘中异动大幅下挫6.37%报2.50美元